Blog #2: Yeezy Yeezy Just Jumped Over Jumpman?

Sneakers can either be something you put on your feet and forget or present-day baseball cards, depending on what type of person you are. The towering giants in the footwear industry are obviously Nike, Adidas, and Jordan. Even if you aren’t a sneaker-head, you definitely have heard of these three brands or maybe even learned about the lengths some consumers go to acquire the shoes they want to add to their collections. From extensive overnight line-ups to violence, these commotions would lead many to assume it’s just another weekend where die-hard fans are yearning to put their hands on a new pair of basketball sneakers. However, just recently on September 19th of 2017, Adidas climbed over Jordan Brand to secure the #2 spot in U.S. sneaker sales despite having endured struggles just a few years earlier. Additionally, their main competitors Jordan Brand and Nike, who actually work together, have been seeing declines rather than growth in recent years. As an avid sneaker collector, myself, it is very interesting to see many elements of business at play in my passion for sneakers. Personally, I, along with others, think that the decline of Nike and Jordan Brand and the growth of Adidas can all be rooted in the recent poor business decisions of Nike. Their efforts in maintaining strict control over their brand resulted in several instances of Adidas gaining a lead over their rivals. Firstly, Nike’s cold shoulder with collaborators resulted in big names such as Kanye West leaving the brand and working with the competition, Adidas, instead. Kanye West’s sneakers being highly demanded meant that Nike effectively scared away easy large-scale publicity as it is likely not a coincidence that Adidas began their rapid growth shortly after welcoming Kanye West onto their team. Secondly, Nike’s lack of innovation in their products while inflating their prices, by pumping out the same sneakers and increasing the prices each time, even the most die-hard of collectors were getting bored. In comparison, Adidas was constantly revamping their product lines, with their recent sneakers utilizing the best of current technology, drew Nike consumers into the German sportswear company and further deteriorating Nike. From this, I realized that in the world of commerce, anything is possible and the tide can turn very easily once any business starts making unwise decisions, getting ahead of themselves and disconnecting from reality as seen with Nike’s overconfident business decisions. Additionally, I realized that it doesn’t matter how influential a business can be since there will always be room for competitors to leap over you as consumers will not wait for you if the other kid on the block has something shinier and cheaper.

 

Imagery Source:

-https://hypebeast.com/2017/2/adidas-boost-technology-explained

 

Blog #1: Business Ethics

Medication and healthcare is a regular aspect for unfortunately, quite a number of people. Just like any other basic necessities in life, any burden to its availability can severely restrict the quality of lives for those who depend on it. Just like practically everything, medication and healthcare is directly connected with the world of business. In fact, according to PricewaterhouseCoopers, the healthcare sector is one of the most impacting industries in society. (Pricewaterhouse Coopers) I mean, lives literally depend on the healthcare sector. Thus, it is crucial business ethics play a heavy role in this industry as if the industry gets too out of hand or crosses the boundary too far, lives can be held at stake. Just last year in 2016, Martin Shkreli made international headlines as his pharmaceutical business disregarded ethical business choices and skyrocketed the price of the drug Daraprim, which is used in the treatment of AIDS and cancer patients, from $13.50 to $750 overnight just because he was able to do so. (The Guardian) This decision severely impacted many Americans who were already suffering from serious illnesses and diseases as now more of their personal finances had to be directed to their basic need of medicine all for the sake of corporate greed. Sadly, some Americans were not even able to afford Daraprim either due to issues with their insurance companies or the simple fact that Shkreli increased the price of the drug by 1800%. (The New York Times) As an acquaintance of a few CEOs of Canadian mining and commodities firms, I have learned first-hand how damaging unethical business choices can be to society especially if said choices are applied to corporations associated with basic resources such as hydro and medication as since commerce connects the world together, by filling this connection with unjust practices, the consequences of unethical business choices only accumulates to affect more individuals and groups. In my opinion, it is simply absurd to value financial gains over the basic livelihoods of others. Although Mr. Shkreli’s monopoly may not suffer from the R. Edward Freeman’s Stakeholder Theory, which dictates that for a business to survive it must create value for their customers, suppliers and other partners, I believe it is still a duty as a valuable member of the commercial world to connect society through commerce and advance the progress of humanity rather than deteriorate the lives of those who are already suffering for a few extra zeros in a quarterly financial statement.

 

Text References:

https://www.pwc.com/us/en/health-industries/top-health-industry-issues.html

https://www.theguardian.com/business/2016/oct/28/martin-shkreli-daraprim-hiv-drug-price-hike-interview

https://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html?mcubz=1

https://www.youtube.com/embed/bIRUaLcvPe8

Imagery Source:

http://money.cnn.com/2016/08/25/news/economy/daraprim-aids-drug-high-price/index.html